ArticleScientific reports2025
Mining, validating, and quantifying circular RNA transcriptome from total RNA as a biomarker or target.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Diagnostic and prognostic role of circular RNAs: Analytical challenges and emerging opportunities.iScience · 2026Review
- CircRNA-regulated programmed cell death networks in cardiomyocytes: Molecular crosstalk and therapeutic translation.Non-coding RNA research · 2026Review
- Unknotting the Role of circRNAs and IGF2BP3 in Alzheimer's Disease.Cellular and molecular neurobiology · 2026Review
- Circular RNA therapeutics: a new class of long-acting RNA medicines for oncology, immunology, and rare diseases.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Circular RNAs (circRNAs) participate in complex diseases and have emerged as a novel biomarker and therapeutic target. It is challenging to identify circRNAs from total RNA-seq data and to validate and quantify their levels by qRT-PCR. We sought to characterize the circRNA transcriptome from RNA-seq with total RNA from septic peripheral blood mononuclear cells (PBMCs), assess/compare commonly used aligners, and optimize validation methods, considering sepsis is the leading cause of death in intensive care units (ICU) and there is no effective treatment. PBMCs were isolated from sepsis patients before and after intensive care, and RNA sequencing was conducted with total RNA. RNA-seq data for circRNAs were analyzed using four pipelines. A circRNA transcriptome has been generated, and four alignment and annotation pipelines have been evaluated. TopHat was found to be the most sensitive aligner while MapSplice was found to be the most accurate. Overall, circRNA expression in septic PBMCs were found to be more abundant and less diverse at ICU admission (ICU-AD) compared with ICU discharge (ICU-DC). There were three differentially expressed circRNAs between ICU-AD and ICU-DC. The addition of reverse primers to a reverse transcription reaction improved reproducibility and accuracy of qRT-PCR. Among these altered circRNAs, two different isoforms of circular RNA from the ASPH gene (circASPH(2,4), and circASPH(2,3,4) with the same backsplicing junction (BSJ) were identified and specifically quantified by qRT-PCR. All the two isoforms were highly expressed at ICU-AD and circASPH(2,3,4) levels positively correlated with the length of stay in ICU. The circRNAs predictably bind to miR-670, miR-7975, miR-6818, and miR-384 and interact with proteins TLR2 and ZC3H12D. In conclusion, it is feasible to identify circRNA transcriptome from RNA-seq with total RNA. Moreover, RT-PCR followed by gel electrophoresis is important to identify/ distinguish a new isoform of a circRNA with the same BSJ. CircRNA transcriptome in septic PBMCs evolves as infectious severity changes. CircASPH(2,3,4) has a clinical potential as an indicator of disease severity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.